208 related articles for article (PubMed ID: 11237835)
1. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection.
Nosanchuk JD; Ovalle R; Casadevall A
J Infect Dis; 2001 Apr; 183(7):1093-9. PubMed ID: 11237835
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide as a novel anticryptococcal agent.
Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
4. Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
Dalisay DS; Saludes JP; Molinski TF
Bioorg Med Chem; 2011 Nov; 19(22):6654-7. PubMed ID: 21715177
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection.
Erives VH; Munzen ME; Zamith-Miranda D; Hernandez H; Manepalli S; Nguyen LN; Hamed MF; Nosanchuk JD; Martinez LR
Infect Immun; 2022 Apr; 90(4):e0009122. PubMed ID: 35357221
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole inhibits melanization in Cryptococcus neoformans.
Martinez LR; Ntiamoah P; Gácser A; Casadevall A; Nosanchuk JD
Antimicrob Agents Chemother; 2007 Dec; 51(12):4396-400. PubMed ID: 17923488
[TBL] [Abstract][Full Text] [Related]
7. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
Chayakulkeeree M; Sorrell TC; Siafakas AR; Wilson CF; Pantarat N; Gerik KJ; Boadle R; Djordjevic JT
Mol Microbiol; 2008 Aug; 69(4):809-26. PubMed ID: 18532984
[TBL] [Abstract][Full Text] [Related]
8. [Melanin and its role on the virulence of Cryptococcus neoformans].
Alp S
Mikrobiyol Bul; 2010 Jul; 44(3):519-26. PubMed ID: 21064003
[TBL] [Abstract][Full Text] [Related]
9. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans.
Walton FJ; Idnurm A; Heitman J
Mol Microbiol; 2005 Sep; 57(5):1381-96. PubMed ID: 16102007
[TBL] [Abstract][Full Text] [Related]
10. Immunology of infection caused by Cryptococcus neoformans.
Wormley FL; Perfect JR
Methods Mol Med; 2005; 118():193-8. PubMed ID: 15888944
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates.
Garcia-Rivera J; Eisenman HC; Nosanchuk JD; Aisen P; Zaragoza O; Moadel T; Dadachova E; Casadevall A
Fungal Genet Biol; 2005 Dec; 42(12):989-98. PubMed ID: 16289955
[TBL] [Abstract][Full Text] [Related]
12. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans.
Silva FD; Rossi DC; Martinez LR; Frases S; Fonseca FL; Campos CB; Rodrigues ML; Nosanchuk JD; Daffre S
FEMS Microbiol Lett; 2011 Nov; 324(1):64-72. PubMed ID: 22092765
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
Khan MA; Nasti TH; Owais M
J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
[TBL] [Abstract][Full Text] [Related]
14. The copper interference with the melanogenesis OF Cryptococcus neoformans.
Mauch RM; Cunha Vde O; Dias AL
Rev Inst Med Trop Sao Paulo; 2013; 55(2):117-20. PubMed ID: 23563765
[TBL] [Abstract][Full Text] [Related]
15. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
Khan MA; Aljarbou A; Khan A; Owais M
FEMS Immunol Med Microbiol; 2012 Oct; 66(1):88-97. PubMed ID: 22612788
[TBL] [Abstract][Full Text] [Related]
16. Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model.
Nasti TH; Khan MA; Owais M
J Antimicrob Chemother; 2006 Feb; 57(2):349-52. PubMed ID: 16368700
[TBL] [Abstract][Full Text] [Related]
17. The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium.
Coenjaerts FE; Hoepelman AI; Scharringa J; Aarts M; Ellerbroek PM; Bevaart L; Van Strijp JA; Janbon G
FEMS Yeast Res; 2006 Jun; 6(4):652-61. PubMed ID: 16696662
[TBL] [Abstract][Full Text] [Related]
18. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.
Mednick AJ; Nosanchuk JD; Casadevall A
Infect Immun; 2005 Apr; 73(4):2012-9. PubMed ID: 15784542
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
20. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
